Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity

por Maria, Durvanei A., Will, Sonia Elisabete A.L., Bosch, Rosemary V., Souza, Jean G., Sciani, Juliana M., Goldfeder, Mauricio B., Rondon, Giuliana G., Chudzinski-Tavassi, Ana M.
Publicado 2018